Piers joined the Cancer Health Service Research unit as a Research Fellow in July of 2019.
Prior to joining the team, Piers completed studies in genetics and neuroscience with a focus on the genetic basis of autism spectrum disorders as well as biomarker identification in schizophrenia; and worked in the biotechnology industry as an R&D scientist for an Australian company, Bio Molecular Systems, before returning to study to complete a Master of Biostatistics. To complete his studies in biostatistics he undertook research at the Murdoch Children’s Research Institute investigating gene-environment interactions in juvenile type 1 diabetes. Upon completion of his studies in biostatistics Piers joined the Cancer Health Services Research Unit.
Piers’ research is looking to identify key metrics that can be used to measure the impact of clinical trials at the VCCC. These metrics will then be used to determine the value of trials funded through the VCCC using “Value-of-Information” methods. Furthermore, his work will extend to collecting additional data and assessing methods of determining clinical trial impact in the real world and whether trials are “practice changing”.
Piers has a Bachelor of Science (Neuroscience and Genetics), Master of Science (Genetics) and Master of Biostatistics, each from the University of Melbourne.
In his spare time Piers enjoys staying active and plays baseball for the University of Melbourne Baseball Club during the winter months while throughout the rest of the year he spends his spare time mountain biking and hiking.